Obesity and Breast Cancer: Interaction or Interference with the Response to Therapy?
Silvia RiondinoVincenzo FormicaElena ValenziCristina MorelliValeria FlaminioIlaria PortarenaFrancesco TorinoMario RoselliPublished in: Current oncology (Toronto, Ont.) (2023)
in radically resected hormone-sensitive BC patients undergoing neoadjuvant or adjuvant chemotherapy and treated with AI, obesity represents a risk factor for recurrence, with a significantly reduced 2-year DFS.
Keyphrases
- insulin resistance
- patients undergoing
- metabolic syndrome
- weight loss
- high fat diet induced
- lymph node
- type diabetes
- weight gain
- rectal cancer
- artificial intelligence
- locally advanced
- stem cells
- adipose tissue
- skeletal muscle
- mesenchymal stem cells
- radiation therapy
- prognostic factors
- deep learning
- newly diagnosed
- breast cancer risk